Intas Pharmaceuticals Acquires Coherus BioSciences’ Udenyca Business (Biosimilar, Neulasta)
Shots: Intas has acquired Coherus’ Udenyca business (incl. prefilled syringe...
Shots: Intas has acquired Coherus’ Udenyca business (incl. prefilled syringe...
Shots: The US FDA has approved Jobevne, a biosimilar version of Avastin (bevacizum...
Shots: Teva & Samsung Bioepis have launched Epysqli, a biosimilar version of S...
Shots: The CHMP has recommended Osvyrti & Jubereq, biosimilar versions of Amge...
Shots: Organon has acquired the US regulatory & commercial rights for Tofidenc...
Shots: The EMA has validated MAA of HLX11, a biosimilar version of Perjeta (pertuz...
Incisive News in 3 Shots.
Modal body text goes here.